FSD Pharma Announces First Patient Randomized in Phase 2 Trial of FSD201 for the Treatment of Hospitalized Patients with COVID-19 Read more
Acceleron Receives Orphan Designation from the European Commission (EC) for Sotatercept in Pulmonary Arterial Hypertension (PAH) Read more
Ashvattha Therapeutics Announces Collaboration With Stanford University for Preclinical Development of a Novel Neuroimaging Agent, OP-801 Read more
Pfizer and BioNTech Provide Data from German Phase 1/2 Study Further Characterizing Immune Response Following Immunization with Lead COVID-19 Vaccine Candidate BNT162b2 Read more
Sonoma and Crown Laboratories Announce an Exclusive Partnership to Launch Microcyn Technology-Based Anti-Itch Over-the-Counter Products Read more
AstraZeneca to acquire Alexion, accelerating the Company’s strategic and financial development Read more
INOVIO and Advaccine Announce First Dosing of Subject in Phase 2 Clinical Trial for COVID-19 DNA Vaccine Candidate INO-4800 in China Read more
Pfizer and BioNTech Receive FDA Advisory Committee Vote Supporting Potential First Emergency Use Authorization for Vaccine to Combat COVID-19 in the U.S. Read more